SELLAS Life Sciences (SLS) Change in Inventory (2013 - 2015)
SELLAS Life Sciences (SLS) posted quarterly Change in Inventory of $789000.0 for Q2 2015, up 952.0% year-over-year from $75000.0 in Q2 2014, and up 4483.33% quarter-over-quarter from -$18000.0 in Q1 2015.
Powered by 
Analysis
SELLAS Life Sciences (SLS) Change in Inventory (2013 - 2015) Analysis & Trends
SELLAS Life Sciences (SLS) has reported Change in Inventory for 3 consecutive years, with $789000.0 the latest figure, recorded in Q2 2015.
- In Q2 2015, Change in Inventory rose 952.0% year-over-year to $789000.0; the TTM figure through Jun 2015 stood at $993000.0 (up 1125.93% YoY), while the FY2014 annual figure was $269000.0, down 30.31% from the prior year.
- Change in Inventory advanced to $789000.0 in Q2 2015 per SLS's latest filing, from -$18000.0 in the prior quarter.
- Across five years, Change in Inventory topped out at $789000.0 in Q2 2015 and bottomed at -$39000.0 in Q4 2013.
- Historically, Change in Inventory has averaged $158444.4 across 3 years, with a median of $73000.0 in 2013.
- Annual changes were most pronounced in 2014 — Change in Inventory plunged 78.69% — and 2015, when it soared 952.0%.
- SELLAS Life Sciences' Change in Inventory stood at -$39000.0 in 2013, then surged by 625.64% to $205000.0 in 2014, then jumped by 284.88% to $789000.0 in 2015.
- Business Quant data shows SLS's Change in Inventory at $789000.0 in Q2 2015, -$18000.0 in Q1 2015, and $205000.0 in Q4 2014.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Inventory (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.78 Bn | 130.92 Bn | 2.84 Bn | 27.70 Mn |
| 2 | Regeneron Pharmaceuticals | 85.50 Bn | 77.51 Bn | 3.93 Bn | 28.20 Mn |
| 3 | Argenx Se | 63.51 Bn | 58.32 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.06 Bn | 52.92 Bn | 52.00 Mn | 132.00 Mn |
| 5 | Revolution Medicines | 44.04 Bn | 44.04 Bn | - | - |
| 6 | BeOne Medicines | 40.04 Bn | 34.94 Bn | 1.53 Bn | 47.15 Mn |
| 7 | Alnylam Pharmaceuticals | 35.45 Bn | 32.14 Bn | 992.69 Mn | -280,000.00 |
| 8 | Royalty Pharma | 28.41 Bn | 27.57 Bn | - | - |
| 9 | Insmed | 27.42 Bn | 26.26 Bn | 358.27 Mn | 12.97 Mn |
| 10 | SELLAS Life Sciences | 2.62 Bn | 2.62 Bn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2015 | 789,000.00 |
| Mar 31, 2015 | -18,000.00 |
| Dec 31, 2014 | 205,000.00 |
| Sep 30, 2014 | 17,000.00 |
| Jun 30, 2014 | 75,000.00 |
| Mar 31, 2014 | -28,000.00 |
| Dec 31, 2013 | -39,000.00 |
| Sep 30, 2013 | 73,000.00 |
| Jun 30, 2013 | 352,000.00 |